% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Streich:826950,
author = {Streich, Carmen and Akkari, Laura and Decker, Christina and
Bormann, Jenny and Rehbock, Christoph and
Müller-Schiffmann, Andreas and Niemeyer, Felix Carlsson and
Nagel-Steger, Luitgard and Willbold, Dieter and Sacca,
Barbara and Korth, Carsten and Schrader, Thomas and
Barcikowski, Stephan},
title = {{C}haracterizing the {E}ffect of {M}ultivalent {C}onjugates
{C}omposed of {A}β-{S}pecific {L}igands and {M}etal
{N}anoparticles on {N}eurotoxic {F}ibrillar {A}ggregation},
journal = {ACS nano},
volume = {10},
number = {8},
issn = {1936-0851},
address = {Washington, DC},
publisher = {Soc.},
reportid = {FZJ-2017-01157},
pages = {7582-7597},
year = {2016},
abstract = {Therapeutically active small molecules represent promising
nonimmunogenic alternatives to antibodies for specifically
targeting disease-relevant receptors. However, a potential
drawback compared to antibody–antigen interactions may be
the lower affinity of small molecules toward receptors.
Here, we overcome this low-affinity problem by coating the
surface of nanoparticles (NPs) with multiple ligands.
Specifically, we explored the use of gold and platinum
nanoparticles to increase the binding affinity of
Aβ-specific small molecules to inhibit Aβ peptide
aggregation into fibrils in vitro. The interactions of bare
NPs, free ligands, and NP-bound ligands with Aβ are
comprehensively studied via physicochemical methods
(spectroscopy, microscopy, immunologic tests) and cell
assays. Reduction of thioflavin T fluorescence, as an
indicator for β-sheet content, and inhibition of cellular
Aβ excretion are even more effective with NP-bound ligands
than with the free ligands. The results from this study may
have implications in the development of therapeutics for
treating Alzheimer’s disease.},
cin = {ICS-6},
ddc = {540},
cid = {I:(DE-Juel1)ICS-6-20110106},
pnm = {553 - Physical Basis of Diseases (POF3-553)},
pid = {G:(DE-HGF)POF3-553},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000381959100041},
pubmed = {pmid:27404114},
doi = {10.1021/acsnano.6b02627},
url = {https://juser.fz-juelich.de/record/826950},
}